Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma.
Zihan XiYuanxin YeYongbo YangYiwei HeZiyang SongQian MaHui ZengGuo-Liang ShaoPublished in: Abdominal radiology (New York) (2024)
The combined clinical-radiomics model is an effective predictor of the short-term efficacy of initial D-TACE in patients with HCC, contributing to clinical and economic benefits for patients.
Keyphrases
- contrast enhanced
- magnetic resonance imaging
- diffusion weighted
- magnetic resonance
- computed tomography
- diffusion weighted imaging
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- squamous cell carcinoma
- radiofrequency ablation
- patient reported outcomes